Compare KOSS & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KOSS | ICCC |
|---|---|---|
| Founded | 1953 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.3M | 55.5M |
| IPO Year | 1994 | 1995 |
| Metric | KOSS | ICCC |
|---|---|---|
| Price | $4.08 | $6.65 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 16.3K | 11.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 10.00 | ★ 65.33 |
| EPS | N/A | ★ 0.20 |
| Revenue | $12,624,170.00 | ★ $26,493,169.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $32.70 |
| Revenue Growth | 2.93 | ★ 51.64 |
| 52 Week Low | $4.00 | $4.32 |
| 52 Week High | $8.59 | $7.60 |
| Indicator | KOSS | ICCC |
|---|---|---|
| Relative Strength Index (RSI) | 43.85 | 56.18 |
| Support Level | $4.07 | $5.72 |
| Resistance Level | $5.04 | $6.87 |
| Average True Range (ATR) | 0.14 | 0.23 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 22.37 | 87.62 |
Koss Corp is engaged in the design, manufacture, and sale of stereo headphones and related accessory products. It operates in the audio/video industry segment of the home entertainment industry. The company markets a line of headphones, wireless Bluetooth headphones, wireless Bluetooth speakers, computer headsets, telecommunications headsets, and active noise-canceling headphones. The majority of the firm's revenue is derived from sales of stereo headphones. The Company also sells products to distributors for resale to school systems, and directly to other manufacturers for inclusion with their own products.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.